About half of the human genome consists of highly repetitive elements, most of which are considered dispensable for human life. Here, we report that repetitive elements originating from endogenous retroviruses (ERVs) are systematically transcribed during human early embryogenesis in a stage-specific manner. Our analysis highlights that the long terminal repeats (LTRs) of ERVs provide the template for stage-specific transcription initiation, thereby generating hundreds of co-expressed, ERV-derived RNAs. Conversion of human embryonic stem cells (hESCs) to an epiblast-like state activates blastocyst-specific ERV elements, indicating that their activity dynamically reacts to changes in regulatory networks. In addition to initiating stage-specific transcription, many ERV families contain preserved splice sites that join the ERV segment with non-ERV exons in their genomic vicinity. In summary, we find that ERV expression is a hallmark of cellular identity and cell potency that characterizes the cell populations in early human embryos.
SUMMARY
About half of the human genome consists of highly repetitive elements, most of which are considered dispensable for human life. Here, we report that repetitive elements originating from endogenous retroviruses (ERVs) are systematically transcribed during human early embryogenesis in a stage-specific manner. Our analysis highlights that the long terminal repeats (LTRs) of ERVs provide the template for stage-specific transcription initiation, thereby generating hundreds of co-expressed, ERV-derived RNAs. Conversion of human embryonic stem cells (hESCs) to an epiblast-like state activates blastocyst-specific ERV elements, indicating that their activity dynamically reacts to changes in regulatory networks. In addition to initiating stage-specific transcription, many ERV families contain preserved splice sites that join the ERV segment with non-ERV exons in their genomic vicinity. In summary, we find that ERV expression is a hallmark of cellular identity and cell potency that characterizes the cell populations in early human embryos.
Endogenous retroviruses (ERVs) are transposable genetic elements that can copy and paste their own DNA into the genome (Cordaux and Batzer, 2009; Kazazian, 2004; Weiss, 2006; Werren, 2011) . Full-length ERVs encode an array of proteins (gag, pol, and env) flanked by two long terminal repeats (LTRs) that contain a regulatory sequence for controlling ERV expression. Because of their ability to copy their own DNA, ERV elements exist in high copy numbers in the human genome (Feschotte and Gilbert, 2012; Gifford and Tristem, 2003; Jern and Coffin, 2008; Rebollo et al., 2012) . Most ERVs are thought to have lost their retroviral activity (Lö wer et al., 1996) , but, in human embryonic stem cells (hESCs), some are still transcribed (Fort et al., 2014; Kapusta et al., 2013; Kelley and Rinn, 2012; Lu et al., 2014; Macia et al., 2011; Santoni et al., 2012) . In particular, many LTR7-HERVH elements produce long non-coding RNAs (lncRNAs) that are required for maintenance of the pluripotent state, suggesting that ERVs can support functions other than their own retrotransposition (Lu et al., 2014) . In mice, expression of the murine ERV-L family is considered an indicator of a totipotent two-cell state (Macfarlan et al., 2012) .
Because of its importance in understanding stem cell regulation, the transcriptome of early embryonic cell populations has been examined in some detail, and many relevant long intergenic non-coding RNA (lincRNA) genes have been identified (Xue et al., 2013; Yan et al., 2013) . However, ERV expression has not been systematically investigated, and it remains unclear whether ERVs contribute in a systematic manner to stem cell potency and identity in early embryos. Here, we comprehensively analyze expression of ERV elements in the human genome using publicly available single-cell RNA sequencing (RNA-seq) data from oocytes (n = 6) and pronuclei (n = 3), zygote (n = 5), two-cell (n = 9), four-cell (n = 16), eight-cell (n = 31), morula (n = 19), and blastocyst stage embryos (n = 30) as well as hESCs (n = 32; in total, 153 100 bp-long, single-and paired-end RNA-seq samples, almost 4 billion mapped reads) (Xue et al., 2013; Yan et al., 2013) .
Initially, to get an overview of the extent of ERV transcription in early embryos, we calculated the fraction of the transcriptome that originated from ERVs and LTR retrotransposons (Figures 1A and S1A) (Smit and Hubley, 2010) . We found that oocytes and zygote to four-cell embryos show the highest percentage of ERV transcripts. From the onset of the eight-cell stage, the fraction of reads that map to ERV elements is gradually reduced. Even though hESCs are most similar to blastocyst cells from their gene expression pattern and developmental stage (Yan et al., 2013) , the amount of ERV expression is drastically different, indicating that the transcriptome of early embryonic cell populations differs from in vitro pluripotent stem cells. To test whether the transcription of ERV elements is stage specific, we performed a principal component analysis (PCA) on the ERV expression estimates. Remarkably, the first two principal components clearly separate every individual developmental stage ( Figures 1B, 1C , S1B, and S1C; Table S1 ), indicating that ERV expression is highly stage specific. This pattern is not an artifact of overlapping protein-coding genes ( Figures 1C and S1D ), suggesting that expression of ERV elements might be regulated independently from protein-coding gene expression. Xue et al. (2013) and Yan et al. (2013) . (B) PCA on the ERV expression estimates in human preimplantation embryos. The 5,000 ERV elements that showed the highest variation between the stages were selected. All ERV elements that overlapped exons were removed. ERV expression is characteristic of the different developmental stages.
(C) Normalized RNA-seq for three loci that show stage-specific ERV expression. Data from single cells is shown in light blue (overlaid), the mean from all samples per stage is indicated in black. The blue boxes highlight the stage-specific ERV elements (HERVK14, THE1A, and HERVK).
(legend continued on next page)
During the early stages of development, the genome is largely permissive for transcription, so ERV elements that reside within transcribed loci are likely to be passively expressed. However, when we averaged the expression for all ERV elements that belonged to the same family (RepeatMasker: repName), we found that the distinct embryonic stages can still be clearly distinguished ( Figure S1E ). This result suggests that expression of ERV elements is not a locus-specific effect caused by permissive transcription but instead a property of the families that the transcribed ERV elements belong to. To identify which ERV families show stage-specific expression in early embryos, we calculated differential expression of all ERV elements from every family at each stage ( Figures 1D, S1F , and S1G). Interestingly, most of the stage-specific ERV elements correspond to the LTRs. Among the LTR families that show stage-specific expression in early embryos are LTR3B, LTR14B (oocyte to four-cell, part of HERVK14), LTR12C (zygote to eight-cell), MLT2A1 (HERVL, eight-cell), THE1A (eight-cell), and LTR5_Hs (HERVK, morula). Two LTR families that flank HERVH are enriched in the eight-cell and morula (LTR7B) and blastocyst stage (LTR7Y) (Figure 1D) . Notably, most of these ERV elements show no systematic activation in adult tissues ( Figure S1H ). For all stage-specific ERV families, we identified the individual elements that are significantly more highly expressed in comparison to the other stages ( Figure 1E , Table S1 ). To validate the robustness of our approach to identifying stage-specific ERV families, we compared the ERV expression estimates with expression estimates for protein-coding genes (Flicek et al., 2014; Love et al., 2014) . We found that ERV expression correlates extremely well with protein-coding gene expression ( Figure 1F , p < 1 3 10 À16 ), suggesting that ERV expression levels provide a robust and quantitative marker of cell identity.
To investigate whether ERV expression can distinguish between heterogeneous cell populations, we looked at single-cell data from the blastocyst, which contains three major cell types, one of which, the epiblast, is pluripotent. First, we ranked all blastocyst cells by their level of NANOG expression, a marker of the pluripotent epiblast ( Figure 1G and 5/30 cells). Then, we calculated differential expression of ERV elements between the NANOG-expressing epiblast and non-epiblast cells ( Figure 1G , Table S1 ). Strikingly, only the epiblast cells express LTR7-HERVH, the HERVH class that contributes to pluripotency of hESCs in cultures (Figures 1G and S1I) . Thus, ERV expression seems to not only demarcate developmental stages but also the distinct cell populations that arise during early embryogenesis.
Next, to compare ERV expression in epiblast cells and hESCs, we identified all ERV elements that showed differential expression ( Figure 2A , Table S1 ). Similar to previous studies (Wang et al., 2014) , we identified a number of HERVH elements with increased expression in epiblast cells. Surprisingly, these epiblast-specific HERVH elements are significantly enriched in the LTR7Y family, the subset of HERVH that is expressed in all blastocyst cells. We also found that a small number of HERVK elements are enriched in the epiblast, which might contribute to the epiblast pluripotency expression signature as well. To examine whether expression of epiblast-specific ERVs can be induced in vitro, we analyzed publicly available RNA-seq data from epiblast-like (naive) hESCs (Chan et al., 2013; Takashima et al., 2014) . Consistently, we found that epiblast-specific ERV elements are significantly more highly expressed in naive hESCs ( Figure 2B , p = 4.3 3 10 À27 ; Figure S2A ). We also validated expression of these ERV elements during conversion from conventional hESCs to epiblast-like 3iL hESCs ( Figure 2C ) and confirmed upregulation of LTR7Y and HERVK, further suggesting that they may serve as markers of the naive state.
To study the crosstalk between the regulatory networks and ERV expression, we investigated publicly available transcription factor binding and histone modification data in conventional and epiblast-like hESCs (Chan et al., 2013) . Enrichment of H3K4me3 supports the role of LTR7 as active promoter ( Figure 2D ). As reported previously, we found that NANOG binds to the LTR7 region of HERVH. Interestingly, NANOG binding in epiblast-like 3iL hESCs is significantly increased at ERV elements, in particular for LTR7 (Fisher's test, p < 1.0 3 10 À300 ), LTR7Y (p = 5.8 3 10 À32 ), and LTR5_Hs (p = 1.1 3 10 À56 ), the LTR elements that form the epiblast-and naive-specific expression signature ( Figures S2B-S2D ). To test whether the activity of LTR7 depends on NANOG expression, we cloned a LTR7 region that is bound by NANOG into the promoter region of a luciferase reporter. The LTR7 sequence results in a significant increase in reporter activity in comparison to the control. Depletion of NANOG reduces the reporter activity by more than 50%, suggesting that NANOG indeed regulates ERV expression ( Figure 2E ). Interestingly, NANOG binding is particularly high at LTR elements that contain two short nucleotide motifs, suggesting that additional co-factors might be involved in sequence-specific regulation of ERVs ( Figure S2E ).
If regulatory elements within the LTR sequence determine stage-specific expression, then sequence similarity should be able to predict this expression pattern even at early stages when no ChIP-seq data are available (Gö ke et al., 2012) . To test this hypothesis, we calculated a multiple sequence alignment for all HERVH-associated LTR elements (LTR7, LTR7Y, and LTR7B) that show stage-specific expression (Katoh and Standley, 2013) (Figures 2F and 2G ; Table S2 ). Strikingly, the alignment identifies four clusters of HERVH elements that are (D) Stage-specific enrichment of ERV families ordered by significance. Significance was calculated with a paired Wilcoxon test on the average expression of ERV elements across RNA-seq replicates in one stage in comparison to the average expression of ERV elements in all other stages. Large families were removed for this analysis (>5,000 elements). (E) Number of ERV family members which are stage-specifically expressed (p < 0.001) and mean normalized expression from single-cell RNA-seq data in early human embryos for the stage-specific ERV elements. (F) Normalized mean expression of the 20 most significantly stage-specific protein-coding genes and normalized expression of stage-specific families of ERVs. The mean of stage-specific ERV elements belonging to the family is shown, and every point corresponds to one RNA-seq experiment. (G) Heatmap showing expression levels of ERV elements in epiblast cells and non-epiblast blastocyst cells. Cells were sorted by the level of NANOG expression, and ERV elements were sorted by the expression fold change between the two groups. Shown are ERV elements with differential expression p value < 0.001 (Wilcoxon test). Significance for enrichment of families was estimated with Fisher's test. See also Figure S1 and Table S1 . (B) Expression of epiblast-specific ERV elements in hESCs and epiblast-like 3iL hESCs (Chan et al., 2013) . Significance was estimated with Wilcoxon's paired test on the mean from three replicates.
(C) Expression of ERV elements in hESCs during the transition to an epiblast-like state (3iL). Total RNA was harvested from cells treated with 3iL media after 2, 4, and 8 days. Control samples were cultured in mTeSR1. Relative expression was obtained after normalization to the control sample. All values are means ± SEM from three independent experiments (n = 3).
expressed in hESCs and epiblast (LTR7), epiblast and blastocyst (LTR7Y), morula and eight-cell (LTR7B), and early stages (LTR7 with a 38 bp deletion), suggesting that the DNA sequence of the LTR elements might indeed be the primary determinant of stage-specific expression of ERV elements. To test this hypothesis directly, we generated a reporter cell line with a blastocystspecific LTR7Y element inserted before the minimal promoter of the GFP expression cassette. As expected, the reporter cell line is inactive in conventional hESCs. However, converting cells to an epiblast-like state with 3iL activated GFP expression ( Figures  2H and 2I) , confirming that the LTR sequence alone is able to drive cell-type-specific gene expression. Some ERV elements generate transcripts that stretch over a large fraction of the proviral DNA, including members of HERVH ( Figure 2G) , HERVK, HERVK14, or THE1A ( Figure 1C ). When we compared the coding potential of transcribed ERVs with known protein-coding and -noncoding genes (Kong et al., 2007) , we found that the internal proviral DNA elements have higher protein-coding potential (score > 1) than the LTR elements (score < 1), as expected ( Figure 2J ). Interestingly, the youngest human ERV, HERVK, still has a coding capacity that is comparable to protein-coding genes. HERVK proteins have been detected in human samples, indicating that ERV transcriptions might still generate protein-coding RNAs (Fuchs et al., 2013; Tö njes et al., 1997 ). However, not many HERVK elements are expressed, and the majority of ERVs are likely to be non-coding and have transcript structures that differ from the ancestral ERVs that they originated from.
To gain insight into the structure of transcripts that are initiated in stage-specific LTR elements, we mapped RNA-seq reads to a multiple sequence alignment. All LTR elements show a clear signal of transcription initiation ( Figure S2F) . Interestingly, only a subset of LTR families showed transcription into the neighboring DNA (LTR7, LTR14B, and LTR12C, among others), suggesting that some ERVs might be spliced ( Figure S2F ). To systematically identify spliced ERV families, we calculated the percentage of ERV elements that contain split RNA-seq reads ( Figure 2K ). The LTR elements of HERVH, HERVK, and HERVK14 (LTR7, LTR7Y, LTR7B, LTR5_Hs, and LTR14B) show a low amount of splicing, indicating that they act as promoter and transcription start or end site for the HERVs.
However, in the case of the HERVL-associated family MLT2A1, 95% of the elements generate spliced transcripts. To characterize these transcripts further, we calculated a multiple sequence alignment and mapped all RNA-seq reads against this alignment as a reference ( Figure 2L , Table S2 ). The data show a clear signal of transcription initiation, confirming that MLT2A1 encodes eight-cell-specific transcription start sites. When we investigated split RNA-seq reads, we found that splicing consistently occurred at the same position for all individual MLT2A1 elements, a highly preserved splice donor site ( Figures 2L and 2M ). Using the information from the split RNAseq reads, we identified the splice acceptor sites. Interestingly, splice acceptor sites resemble the typical nucleotide motif , indicating that splicing is not an artifact but occurs at designated splice site sequences ( Figure 2M ). Splice acceptor sites are located several kilobases downstream, and the majority (83%) joined non-ERV DNA ( Figure S2G) . Most of the transcripts that are initiated in MLT2A1 are unannotated, indicating that they generate uncharacterized non-coding RNAs ( Figure 2N ). Remarkably, systematic splicing of stage-specific ERV elements is a common phenomenon both for LTR and non-LTR ERV elements. We find that ERV families such as MER73, HERVH, HERVK, or THE1A contain preserved splice donor sites that connects the retroviral element with non-ERV splice acceptor sites of unannotated transcripts (Figures 2O, (D) NANOG binding and H3K4me3 at LTR7-HERVH elements in 3iL hESCs. Boxplots represent the distribution of read counts for expressed LTR7-HERVH elements which were split into 100 equally sized segments. (E) Activity of control promoter and LTR7 driven Renilla luciferase during NANOG knockdown (KD). Renilla luciferase activity was normalized to firefly luciferase activity. Normalized Renilla luciferase activity of control KD sample is set as 1. Biological triplicate data (n = 3) is presented as mean ± SEM. (F) Left, sequence alignment of stage-specific LTR7, LTR7B, and LTR7Y elements. Clustering was performed with hierarchical clustering on the basis of the hamming distance. The color indicates percentage identity. Right, expression estimates for all LTR elements shown in the alignment (left). The clustering of LTR elements on the basis of sequence similarity clusters LTR elements in groups that are co-expressed in early embryos, indicating that the DNA sequence of the LTR elements potentially determines the expression pattern. See also Figure S2 and Table S2. 2P, S2F, and S2G). These results indicate that ERV elements provide a template that generates stage-specific co-regulated transcripts that share a similar ERV derived RNA segment but are otherwise of potentially large biological diversity.
Overall, in this meta-analysis, we have taken advantage of recently generated single-cell RNA-seq data from early human embryos (Xue et al., 2013; Yan et al., 2013) to investigate the genome-wide contribution of ERV elements in this context. Our analysis shows that ERV expression is a common phenomenon in pre-implantation embryos that is systematically regulated and generates large numbers of co-expressed, stage-specific transcripts. To overcome the challenges associated with analysis of repetitive genomic elements, we used only uniquely mappable reads from 100 bp RNA-seq data and found that these are sufficient to detect stage-specific transcription. Integrating reads that map to multiple locations increases the coverage for most repeats but does not change the overall results (Figures S1C and S1F). We also looked at data from two independent studies and found strong similarity, and we are therefore confident that our findings are robust.
ERVs are a major source of genetic innovation and can generate primate-specific regulatory sites that act as enhancers or transcription start sites of nearby genes (del Rosario et al., 2014; Faulkner et al., 2009; Feschotte and Gilbert, 2012; Jacques et al., 2013; Kunarso et al., 2010; Rebollo et al., 2012) . Here, we show that the regulatory elements of ERVs systematically control their own stage-specific expression in human embryos. We also found that ERVs contain preserved splice sites that connect a large number of stage-specific, almost identical ERV-derived RNA segments with a highly diverse repertoire of non-ERV exons and that some elements, including HERVH, HERVK, or THE1A, may generate full-length ERV transcripts, so the distinct ERV families contribute in different ways to the transcriptome.
In addition to the repressive mechanisms that exist to contain the destructive nature of retrotransposons, such as ERVs during embryogenesis Rowe et al., 2010; Smith et al., 2014) , our data suggest that at least a subset of ERV-derived RNAs are regulated by other mechanisms. For example, in hESCs, we find that the sequence-specific transcription factor NANOG regulates LTR7 expression. The eight-cell-specific MLT2A1 family contains regulatory sequences that are also a potential target of transcription factors (Young et al., 2013) . Therefore, the dynamic expression pattern of ERV families may result from a combination of activating and silencing mechanisms that integrate ERV elements into the regulatory networks of early human embryos. In summary, our study demonstrates that human ERV elements regulate and generate a variety of stage-specific RNAs in early human embryos. Only a subset of the elements we have characterized have been studied thus far in other contexts, and our analysis therefore highlights the unexplored potential of ERVs to tag, characterize, maintain, or induce cellular identity in pluripotent cells. 
